Let us talk a little bit about treatment and again this is not all treatments, this is just pharma, is one example, so these are the top players by revenues. So I talked a little about the risk, so they need to reduce costs by 100 million, reduce times by this clinical success by that to do this. ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
